Skip Navigation


Rheumatology Advance Access originally published online on October 26, 2005
Rheumatology 2005 44(12):1507-1513; doi:10.1093/rheumatology/kei083
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
44/12/1507    most recent
kei083v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Baranda, L.
Right arrow Articles by González-Amaro, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Baranda, L.
Right arrow Articles by González-Amaro, R.
Related Collections
Right arrow Systemic Lupus Erythematosus and Autoimmunity
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2005. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

IL-15 and IL-15R in leucocytes from patients with systemic lupus erythematosus

L. Baranda1,2,{dagger}, H. de la Fuente1,{dagger}, E. Layseca-Espinosa1, D. Portales-Pérez3, P. Niño-Moreno1, G. Valencia-Pacheco1, C. Abud-Mendoza3, J. Alcocer-Varela4 and R. González-Amaro1

1 Departamento de Inmunología, Facultad de Medicina, UASLP, 2 Unidad Regional de Reumatología y Osteoporosis Hospital Central Dr Ignacio Morones Prieto, 3 Laboratorio de Inmunología, Facultad de Ciencias Químicas, UASLP, San Luis Potosí, SLP and 4 Departamento de Inmunología y Reumatología, Instituto Nacional de Ciencias Médicas y de la Nutrición Salvador Zubirán, México, DF, México.

Correspondence to: R. González-Amaro, Departamento de Inmunología, Facultad de Medicina, UASLP, Ave. V. Carranza 2405, 78210 San Luis Potosí, SLP, México. E-mail: rgonzale{at}uaslp.mx

Objective. To assess the functional status of the IL-15/IL-15R{alpha} cytokine system in different leucocyte subsets from patients with systemic lupus erythematosus (SLE).

Methods. Eighteen patients with SLE (10 with inactive and eight with active disease) and 14 healthy individuals were studied. Serum levels and in vitro production of IL-15 were determined. In addition, the expression of IL-15 receptor {alpha} (IL-15R{alpha}) and membrane-bound IL-15 was assessed and the in vitro effects of IL-15 on CD69 and CD64 expression, interferon-{gamma} and TNF-{alpha} synthesis, respiratory burst induction and apoptosis were studied.

Results. Serum levels of IL-15 were significantly increased in inactive and active patients with SLE. Accordingly, the in vitro synthesis and release of IL-15 by monocytes in response to IFN-{gamma}+lipopolysaccharide was significantly enhanced in SLE patients with active disease, as was the percentage of membrane-bound IL-15+ monocytes. On the other hand, enhanced basal expression of IL-15R{alpha} was detected in leucocytes from SLE patients, with defective induction upon stimulation with phytohaemagglutinin or phorbol myristate acetate/ionomycin. Furthermore, diminished induction of CD69 expression and interferon-{gamma} and TNF-{alpha} synthesis by recombinant human IL-15 was detected in peripheral blood mononuclear cells from SLE, and there was defective induction of CD64 and priming for respiratory burst in neutrophils. The anti-apoptotic effect of IL-15 was diminished in leucocytes from SLE patients.

Conclusion. Our data indicate that there is enhanced synthesis of IL-15 by immune cells from SLE patients, with a poor response to this cytokine by different leucocyte subsets. This abnormal function of IL-15/IL-15R{alpha} may contribute significantly to the pathogenesis of SLE.

KEY WORDS: Cytokines, Autoimmunity, Apoptosis, CD69, Lymphocytes

{dagger}L.B. and H. de la F. contributed equally to this work.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.